EU Platform Trial To Fast-Track Developing & Testing Depression Treatments

A new depression trial taking place across six European countries to test the safety and efficacy of multiple treatments will initially focus on repurposed drugs approved for other indications. There are plans to expand to Phase III settings and include additional treatments based on stakeholder input.